CSN Login
Members Online: 13

Livatag(R) shows significant survival increase in advanced hepatocellular carcinoma patients

Posts: 5
Joined: Feb 2011

Read this article today about Livatg which says that it extends survival benefits to 32 month in comparison of current 17 months.

Can some one suggest about it.


Subscribe with RSS
About Cancer Society

The content on this site is for informational purposes only. It is not a substitute for professional medical advice. Do not use this information to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition. Use of this online service is subject to the disclaimer and the terms and conditions.

Copyright 2000-2015 © Cancer Survivors Network